Results 271 to 280 of about 57,164 (280)

Effectiveness of early intervention and combination treatment with monoclonal antibodies and antivirals in oncohematological patients with SARS-CoV-2: a retrospective experience. [PDF]

Front Immunol
Di Bari S, Izzo F, Bresciani L, Mancarella G, Garattini S, Gasperin A, Di Trento D, Grimaldi A, Parente A, Marocco R, Carraro A, Kertusha B, Tieghi T, Del Borgo C, Vita S, Guardiani M, Pasquazzi C, Spagnoli A, Alunni Fegatelli D, Lichtner M.   +19 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Remdesivir-Associated Pancreatitis

American Journal of Therapeutics, 2021
Abstract We report a case of acute pancreatitis that developed after four days of remdesivir therapy in a patient being treated for COVID-19. Despite improvement in patient's respiratory status, abdominal pain worsened and clinical signs and symptoms progressed to a diagnosis of acute pancreatitis 4 days after initiation of remdesivir therapy.
Shantanu Solanki, Karen Williams, Sushmita Khadka   +2 more
openaire   +2 more sources

Remdesivir-Induced Bradycardia

Southern Medical Journal, 2023
Remdesivir, a viral RNA-dependent RNA polymerase inhibitor, found extensive use in coronavirus disease 2019-infected patients because it curbs the viral load expansion. Among patients hospitalized as a result of lower respiratory tract infection, remdesivir proved to improve recovery time; however, remdesivir also can induce significant cytotoxic ...
Sai Gautham, Kanagala, Hardeep, Dholiya, Poonam, Jhajj, Meet A, Patel, Vasu, Gupta, Sachin, Gupta, Shiau-Ing, Wu, Rohit, Jain   +7 more
openaire   +2 more sources

Remdesivir for the treatment of COVID-19

Cochrane Database of Systematic Reviews, 2021
Remdesivir is an antiviral medicine with properties to inhibit viral replication of SARS-CoV-2. Positive results from early studies attracted media attention and led to emergency use authorisation of remdesivir in COVID-19.  A thorough understanding of the current evidence regarding the effects of remdesivir as a treatment for SARS-CoV-2 infection ...
Volker Thieme, Miriam Stegemann, Kelly Ansems, Karolina Dahms, Agata Mikolajewska, Maria-Inti Metzendorf, Felicitas Grundeis, Carina Benstoem, Falk Fichtner, Vanessa Piechotta   +9 more
openaire   +2 more sources

Remdesivir (Veklury)

Canadian Journal of Health Technologies
Reimbursement reviews are comprehensive assessments of the clinical effectiveness and cost-effectiveness, as well as patient and clinician perspectives, of a drug or drug class. The assessments inform nonbinding recommendations that help guide the reimbursement decisions of Canada’s federal, provincial, and territorial governments, with the ...
openaire   +2 more sources

Synthesis of Remdesivir [PDF]

Synfacts, 2020
openaire   +1 more source

Synthesis of a Remdesivir Intermediate

Synfacts, 2020
openaire   +2 more sources